Nobel Prize-winning economist Paul Romer provides “a recap with links about how the FDA responded to just a couple of issues since the start of the pandemic.”
Writes Romer:
It might be time to review the massive damage that the FDA is doing by restricting the supply and use of tests for the SARS-CoV-2 virus.
Massive? With enough tests, the US could have avoided the enormous cost that this virus is imposing – at least 200,000 excess deaths and $8 trillion in lost output.
[…]
Many accounts have noted how the failure of the virus test developed by the CDC delayed the US response to the virus. The fact that has not gotten as much attention is that although the FDA promptly approved the broken test from the CDC, it took an excruciatingly long time to approve tests that actually worked.
Read The FDA’s Perpetual Process Machine.
Related articles: